Israeli Prime Minister Netanyahu Confirms Prostate Cancer Diagnosis and Recovery

Israeli Prime Minister Benjamin Netanyahu has confirmed that he was diagnosed with early-stage prostate cancer and has since fully recovered following successful treatment. The disclosure comes after a period of delayed reporting, which officials attributed to ongoing wartime conditions and security considerations.

According to the prime minister’s office, the diagnosis was made in December 2024 following a surgical procedure to address benign prostate enlargement. During the operation, medical professionals identified a suspicious lesion, which subsequent tests confirmed as early-stage prostate cancer. The condition had not spread beyond the prostate gland at the time of detection.

Netanyahu stated that he underwent radiation therapy as the primary course of treatment. Medical assessments indicate the intervention was successful, and follow-up evaluations show no remaining signs of the disease. The prime minister emphasized that his health has returned to normal and that he continues to carry out his official duties without interruption.

The decision to withhold the diagnosis from public view was made in coordination with security and medical advisors, who cited the volatile regional situation and the need to maintain operational stability. The announcement was released as part of a routine health update, with officials noting that the prime minister’s condition was closely monitored throughout the treatment period.

Netanyahu remains in office as Israel continues to navigate complex regional security dynamics. The confirmation of his health status addresses months of speculation regarding his medical condition and underscores the administration’s approach to managing personal health disclosures during periods of national crisis.